Skip to main content
. 2022 Aug 19;47(12):722–727. doi: 10.1136/rapm-2022-103881

Table 1.

Characteristics by responder status

Variable Overall cohort* Responder*† Non-responder*† P value‡
Sample size, n 40 23 17
Mean age (SD) in years 67.9 (12.9) 67.8 (12.2) 68.0 (14.3) 0.97
Sex, n (%)
 Female 18 (45.0) 10 (43.5) 8 (47.0) 1.00
 Male 22 (55.0) 13 (56.5) 9 (53.0)
Body mass index (SD) in kg/m2 31.3 (5.7) 31.7 (4.2) 31.0 (7.4) 0.67
Current tobacco use, n (%) 10 (25.0) 5 (21.7) 5 (29.4) 0.72
Opioid use, n (%) 17 (42.5) 8 (34.8) 9 (53.0) 0.34
Daily OME (SD) in mg 13.2 (22.3) 8.8 (18.1) 15.0 (25.6) 0.38
Neuropathic medication use, n (%) 20 (50.0) 14 (60.9) 6 (35.3) 0.20
Preimplant NRS pain score (SD) 8.3 (1.4) 8.2 (1.5) 8.4 (1.0) 0.75
Preholiday NRS pain score (SD) 7.3 (1.7) 7.0 (1.7) 7.7 (1.5) 0.18
Time from implant to holiday (SD) in days 452.7 (326.4) 451.1 (277.7) 453.4 (355.9) 0.98
Length of holiday (SD) in days 17.3 (20.6) 13.0 (8.4) 20.5 (27.3) 0.23
Type of waveform after holiday, n (%)
 10 kHz 34 (85.0) 22 (95.6) 12 (70.6) 0.07
 Tonic/10 kHz combination 6 (15.0) 1 (4.3) 5 (29.4)
Pain diagnosis, n (%)
 FBSS 26 (65.0) 12 (52.2) 14 (82.4) 0.09
 NSRBP 9 (22.5) 7 (30.4) 2 (11.8) 0.26
 PDN 2 (5.0) 2 (8.7) 0 (0) 0.50
 Radiculopathy 2 (5.0) 1 (4.3) 1 (5.9) 1.00
 Peripheral neuropathy 1 (2.5) 1 (4.3) 0 (0) 1.00

Baseline characteristics are reported at the time of stimulation holiday initiation.

Comparisons were made using independent t-test for continuous outcomes and Fisher’s exact test for categorical outcomes.

*Mean±SD presented for continuous outcomes and frequency with percentage presented for categorical outcomes.

†Responder status denotes ≥50% relief in pain intensity after stimulation holiday, whereas non-responder status denotes <50% relief in pain intensity after stimulation holiday.

‡Independent sample t-tests used to compare means and Fisher’s exact test used to compare proportions between responders and non-responders.

FBSS, failed back surgery syndrome; NRS, Numeric Rating Scale; NSRBP, non-surgical refractory back pain; OME, oral morphine equivalent; PDN, painful diabetic neuropathy.